S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
A Hot Tech Company With Strong Patents & Partners (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
A Hot Tech Company With Strong Patents & Partners (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
A Hot Tech Company With Strong Patents & Partners (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
A Hot Tech Company With Strong Patents & Partners (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
NASDAQ:CUTR

Cutera - CUTR Stock Forecast, Price & News

$50.70
+1.75 (+3.58%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$48.67
$50.82
50-Day Range
$36.55
$50.70
52-Week Range
$31.62
$74.38
Volume
181,428 shs
Average Volume
266,151 shs
Market Capitalization
$992.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$70.75

Cutera MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
39.5% Upside
$70.75 Price Target
Short Interest
Bearish
25.72% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.41mentions of Cutera in the last 14 days
Based on 17 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.88) to ($0.20) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.74 out of 5 stars

Computer And Technology Sector

502nd out of 665 stocks

Electromedical Equipment Industry

18th out of 25 stocks

CUTR stock logo

About Cutera (NASDAQ:CUTR) Stock

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

Cutera Price Performance

Shares of CUTR Stock traded up $1.75 during trading hours on Friday, reaching $50.70. The stock had a trading volume of 181,428 shares, compared to its average volume of 266,151. The stock's fifty day simple moving average is $41.80 and its 200 day simple moving average is $46.88. The firm has a market capitalization of $992.71 million, a PE ratio of -13.81 and a beta of 1.86. Cutera has a 12 month low of $31.62 and a 12 month high of $74.38. The company has a current ratio of 4.36, a quick ratio of 3.83 and a debt-to-equity ratio of 12.56.

Cutera (NASDAQ:CUTR - Get Rating) last posted its earnings results on Thursday, August 4th. The medical device company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.01). The firm had revenue of $64.22 million during the quarter, compared to analysts' expectations of $63.42 million. Cutera had a negative return on equity of 151.43% and a negative net margin of 27.62%. The business's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.39 earnings per share. On average, equities research analysts predict that Cutera will post -1.88 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. StockNews.com downgraded Cutera from a "hold" rating to a "sell" rating in a research note on Thursday, May 12th. Stephens lifted their target price on shares of Cutera from $68.00 to $78.00 in a research note on Monday, May 9th. Maxim Group restated a "buy" rating and set a $80.00 price target on shares of Cutera in a research note on Friday, August 5th. Piper Sandler reduced their price objective on shares of Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Friday, August 5th. Finally, TheStreet downgraded Cutera from a "c-" rating to a "d+" rating in a research report on Thursday, July 7th.

Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

CUTR Stock News Headlines

Piper Sandler Cuts Cutera (NASDAQ:CUTR) Price Target to $55.00
Cutera (CUTR) Q2 2022 Earnings Call Transcript
Cutera: Q2 Earnings Snapshot
Cutera (CUTR) Reports Q2 Loss, Lags Revenue Estimates
Cutera Announces Second Quarter 2022 Financial Results
See More Headlines
Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

CUTR Company Calendar

Last Earnings
8/04/2022
Today
8/14/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:CUTR
Employees
461
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$70.75
High Stock Price Forecast
$80.00
Low Stock Price Forecast
$55.00
Forecasted Upside/Downside
+39.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$2.06 million
Pretax Margin
-27.22%

Debt

Sales & Book Value

Annual Sales
$231.27 million
Cash Flow
$0.33 per share
Book Value
$1.22 per share

Miscellaneous

Free Float
19,164,000
Market Cap
$992.71 million
Optionable
Optionable
Beta
1.86

Social Links















CUTR Stock - Frequently Asked Questions

Should I buy or sell Cutera stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CUTR shares.
View CUTR analyst ratings
or view top-rated stocks.

What is Cutera's stock price forecast for 2022?

2 Wall Street analysts have issued 12-month price targets for Cutera's shares. Their CUTR share price forecasts range from $55.00 to $80.00. On average, they predict the company's share price to reach $70.75 in the next year. This suggests a possible upside of 39.5% from the stock's current price.
View analysts price targets for CUTR
or view top-rated stocks among Wall Street analysts.

How have CUTR shares performed in 2022?

Cutera's stock was trading at $41.32 at the beginning of the year. Since then, CUTR stock has increased by 22.7% and is now trading at $50.70.
View the best growth stocks for 2022 here
.

When is Cutera's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our CUTR earnings forecast
.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) posted its quarterly earnings results on Thursday, August, 4th. The medical device company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.23) by $0.01. The medical device company earned $64.22 million during the quarter, compared to the consensus estimate of $63.42 million. Cutera had a negative net margin of 27.62% and a negative trailing twelve-month return on equity of 151.43%. The firm's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.39 earnings per share.

What guidance has Cutera issued on next quarter's earnings?

Cutera updated its FY 2022 earnings guidance on Thursday, August, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $255.00 million-$260.00 million, compared to the consensus revenue estimate of $261.32 million.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (5.80%), Gamco Investors INC. ET AL (5.51%), First Light Asset Management LLC (3.94%), Cowen AND Company LLC (3.28%), Emerald Advisers LLC (2.53%) and Eagle Asset Management Inc. (2.42%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth and Timothy J Oshea.
View institutional ownership trends
.

How do I buy shares of Cutera?

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $50.70.

How much money does Cutera make?

Cutera (NASDAQ:CUTR) has a market capitalization of $992.71 million and generates $231.27 million in revenue each year. The medical device company earns $2.06 million in net income (profit) each year or ($3.67) on an earnings per share basis.

How many employees does Cutera have?

The company employs 461 workers across the globe.

When was Cutera founded?

Cutera was founded in 1998.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.

This page (NASDAQ:CUTR) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.